111 related articles for article (PubMed ID: 17969146)
1. Amphotropic retrovirus transduction is inhibited by high doses of particle-associated envelope proteins.
Landázuri N; Le Doux JM
Biotechnol Bioeng; 2008 Apr; 99(5):1205-15. PubMed ID: 17969146
[TBL] [Abstract][Full Text] [Related]
2. Complexation with chondroitin sulfate C and Polybrene rapidly purifies retrovirus from inhibitors of transduction and substantially enhances gene transfer.
Landázuri N; Le Doux JM
Biotechnol Bioeng; 2006 Jan; 93(1):146-58. PubMed ID: 16240439
[TBL] [Abstract][Full Text] [Related]
3. Envelope fusion protein binding studies in an inducible model of retrovirus receptor expression and in CD34(+) cells emphasize limited transduction at low receptor levels.
Kurre P; Morris J; Miller AD; Kiem HP
Gene Ther; 2001 Apr; 8(8):593-9. PubMed ID: 11320405
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery.
Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M
J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185
[TBL] [Abstract][Full Text] [Related]
5. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
6. Lentiviruses inefficiently incorporate human parainfluenza type 3 envelope proteins.
Jung C; Le Doux JM
Biotechnol Bioeng; 2008 Mar; 99(4):1016-27. PubMed ID: 17705232
[TBL] [Abstract][Full Text] [Related]
7. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein.
Zavorotinskaya T; Albritton LM
Mol Ther; 2001 Mar; 3(3):323-8. PubMed ID: 11273774
[TBL] [Abstract][Full Text] [Related]
8. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
9. Murine leukemia virus particles activate Rac1 in HeLa cells.
Krishna D; Le Doux JM
Biochem Biophys Res Commun; 2006 Jul; 345(3):1184-93. PubMed ID: 16716260
[TBL] [Abstract][Full Text] [Related]
10. Improved retroviral packaging lines derived from spleen necrosis virus.
Martinez I; Dornburg R
Virology; 1995 Apr; 208(1):234-41. PubMed ID: 11831705
[TBL] [Abstract][Full Text] [Related]
11. Low-level expression of functional foamy virus receptor on hematopoietic progenitor cells.
von Laer D; Lindemann D; Roscher S; Herwig U; Friel J; Herchenröder O
Virology; 2001 Sep; 288(1):139-44. PubMed ID: 11543666
[TBL] [Abstract][Full Text] [Related]
12. High efficiency and long-term foreign gene expression in cultured liver sinusoidal endothelial cells by retroviral transduction.
Paez J; Montaño R; Benatuil L; Iacomini J; Cardier JE
Endothelium; 2006; 13(4):279-85. PubMed ID: 16990184
[TBL] [Abstract][Full Text] [Related]
13. Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells.
Grabarczyk P; Wysocki PJ; Gryska K; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):333-9. PubMed ID: 12362974
[TBL] [Abstract][Full Text] [Related]
14. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer in human skin with different pseudotyped HIV-based vectors.
Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
[TBL] [Abstract][Full Text] [Related]
16. Transduction efficiency of cell lines and hematopoietic stem cells correlates with retrovirus receptor mRNA levels.
Orlic D; Girard LJ; Anderson SM; Do BK; Seidel NE; Jordan CT; Bodine DM
Stem Cells; 1997; 15 Suppl 1():23-8; discussion 28-9. PubMed ID: 9368321
[TBL] [Abstract][Full Text] [Related]
17. Selection of feline leukemia virus envelope proteins from a library by functional association with a murine leukemia virus envelope.
Bupp K; Sarangi A; Roth MJ
Virology; 2006 Aug; 351(2):340-8. PubMed ID: 16678875
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of retrovirus production and decay.
Le Doux JM; Davis HE; Morgan JR; Yarmush ML
Biotechnol Bioeng; 1999 Jun; 63(6):654-62. PubMed ID: 10397822
[TBL] [Abstract][Full Text] [Related]
19. Genistein, a protein tyrosine kinase inhibitor, suppresses the fusogenicity of Moloney murine leukemia virus envelope protein in XC cells.
Kubo Y; Ishimoto A; Amanuma H
Arch Virol; 2003 Oct; 148(10):1899-914. PubMed ID: 14551814
[TBL] [Abstract][Full Text] [Related]
20. Reexamination of amphotropic murine leukemia virus neurovirulence: neural stem cell-mediated microglial infection fails to induce acute neurodegeneration.
Traister RS; Lynch WP
Virology; 2002 Feb; 293(2):262-72. PubMed ID: 11886246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
